A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer

This study has been completed.
Information provided by:
Fox Chase Cancer Center
ClinicalTrials.gov Identifier:
First received: February 15, 2007
Last updated: February 11, 2010
Last verified: February 2010

RATIONALE: A new radiation therapy planning system may help doctors plan better treatment for patients with cancer.

PURPOSE: This clinical trial is studying a new radiation therapy planning system in patients undergoing radiation therapy for extracranial cancer.

Condition Intervention
Unspecified Adult Solid Tumor, Protocol Specific
Radiation: radiation therapy

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Evaluation of the Radionics Body Localizer System and XPLAN/IMRT for Extra-Cranial Sites: A Pilot Study

Resource links provided by NLM:

Further study details as provided by Fox Chase Cancer Center:

Estimated Enrollment: 60
Study Start Date: June 2002
Study Completion Date: August 2005
Detailed Description:


  • Determine the ability of the Radionics Body System™ to immobilize and re-localize patients receiving radiotherapy to extra-cranial sites of cancer.
  • Determine the accuracy of radiation dose calculations for extra-cranial sites of cancer when using the XPLAN™-intensity modulated radiation therapy (XPLAN™/IMRT) integrated software in this system.

OUTLINE: Patients receiving radiotherapy have a Body Localizer cast constructed and undergo a CT scan while immobilized in the Body Localizer. Patients undergo another CT scan in the treatment position using the standard alpha cradle. The XPLAN™-intensity modulated radiation therapy (XPLAN™/IMRT)-generated treatment plan is compared to the standard treatment plan to verify that the calculated dose is within 2-3 percent of the planned dose using standard technique. Patients undergo sets of CT scans 3 additional times over the next few weeks for a total of 8 CT scans Patients may undergo additional CT scans before and after radiotherapy treatments for a maximum of 5 CT scans per week performed over the course of radiotherapy.

PROJECTED ACCRUAL: Approximately 60 patients will be accrued for this study.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No


  • Cancer for which a course of radiotherapy to an extra-cranial site is required

    • Head and neck sites excluded
  • Initial treatment field (or cone down field) must be no greater than 12 X 10 cm



  • Not specified

Performance status

  • Not specified

Life expectancy

  • Not specified


  • Not specified


  • Not specified


  • Not specified


  • No right heart insufficiency


  • Not pregnant or nursing
  • Fertile patients must use effective contraception
  • Weight must not exceed 150 kilograms (330 pounds)


Biologic therapy

  • Not specified


  • Not specified

Endocrine therapy

  • Not specified


  • See Disease Characteristics


  • Not specified
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00436397

United States, Pennsylvania
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States, 19111-2497
Sponsors and Collaborators
Fox Chase Cancer Center
Study Chair: Steven Seigenberg, MD Fox Chase Cancer Center
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00436397     History of Changes
Other Study ID Numbers: CDR0000304713, P30CA006927, FCCC-02604
Study First Received: February 15, 2007
Last Updated: February 11, 2010
Health Authority: United States: Federal Government

Keywords provided by Fox Chase Cancer Center:
unspecified adult solid tumor, protocol specific

ClinicalTrials.gov processed this record on April 17, 2014